揭示蛋白激酶的进步:从概念到临床
Shristi Singh1, Ajita Paliwal1, Niranjan Kaushik1
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
Current protein & peptide science
|September 26, 2025
概括
蛋白激酶抑制剂 (PKI) 是关键的向癌症疗法. 研究探讨了它们的机制,在各种癌症中的应用,以及克服耐药性的策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 蛋白激酶抑制剂 (PKIs) 向重要的酶,控制细胞功能的激酶活性.
- 失调的激酶信号传递是癌症的标志,使PKI成为有希望的向治疗方法.
- 基于它们的结合机制,PKI被分为五种类型 (类型I-V).
研究的目的:
- 提供对最近蛋白激酶抑制剂 (PKI) 研究进展的全面审查.
- 讨论PKI在癌症治疗中的机制,治疗应用和抵抗策略.
- 突出下一代PKI和组合方法的重要性.
主要方法:
- 关于蛋白激酶抑制剂的最新科学文献的综述.
- 基于约束机制的PKI分类分析.
- 检查PKI在各种癌症类型和抵抗机制中的应用.
主要成果:
- PKI在治疗白血病,黑色素瘤,肺癌,乳腺癌和癌方面表现有前途.
- 特定的PKI改善了HER2+乳腺癌,EGFR/ALK突变肺癌和慢性髓性白血病的结果.
- 耐药性机制仍然是一个挑战,需要进一步研究新的PKI和组合疗法.
结论:
- 蛋白质激酶抑制剂在向癌症治疗方面取得了重大进展.
- 持续的研究对于开发下一代PKI和组合策略来克服耐药性和改善临床结果至关重要.
- 了解PKI机制和耐药性途径是促进癌症治疗的关键.
相关概念视频
Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
Protein Kinases and Phosphatases
4.4K
4.4K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K


